Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response

Br J Haematol. 2022 Feb;196(3):e27-e29. doi: 10.1111/bjh.17806. Epub 2021 Aug 30.

¹ Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Department of Infectious Disease, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁴ Department for BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁵ Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
⁶ Division of Hematology, Basel University Hospital, University of Basel, Basel, Switzerland.
⁷ Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.

No abstract available

Keywords: COVID-19; case report; chronic lymphocytic leukaemia; convalescent plasma; remdesivir.

Publication types